Exonate is a biotech company spun out of the University of Nottingham that is focused on alternative splicing of (VEGF) in ophthalmology.

Biotechnology

Health Care

Health Diagnostics

Life Sciences

Pharmaceutical

Exonate

Exonate's headquarters in Cambridge, United Kingdom

Olav Hellebø

Sam Fazeli

Lloyd Paul Aiello

Usha Chakravarthy

Robyn Guymer

Sunil Shah

John Kurek

Andrew Dick

Peter Campochiaro

Chris Torrance

Steven Harper

The Clinical Advisory Team at Exonate provides expert guidance on clinical strategies and trials focused on alternative splicing therapies for VEGF in ophthalmology. They offer insights into patient care, regulatory compliance, and the effectiveness of the company’s treatments in real-world medical scenarios.

Clinical Advisory Team

This department provides strategic direction and oversight for the organization.

Executive Leadership

This department oversees the strategic direction and ethical oversight of the organization through the board of directors.

Board Governance

This department manages the organization's financial activities, including budgeting, forecasting, and financial reporting.

Finance Department

The Science Team at Exonate, consisting of the Head Of Biology, Senior Scientist - Pharmacology, and Senior Scientist, conducts advanced research and development to explore the alternative splicing of VEGF for innovative ophthalmological treatments. Their work involves cutting-edge experimentation, data analysis, and collaboration with other departments to drive new therapeutic solutions.

Exonate

Org chart

Board & advisors

Teams

Clinical Advisory Team

Executive Leadership

Board Governance

Finance Department

Science Team

Offices

Exonate

Org chart

Board & advisors

Teams

Clinical Advisory Team

Executive Leadership

Board Governance

Finance Department

Science Team

Offices

Related companies